序号 |
标题 |
次数 |
作者 |
发布时间 |
81586 |
DOTA-cCCK,DOTA偶联胆囊收缩素(CCK)受体 |
118 |
wyh |
2024-12-03 |
81587 |
3,6-d氨基-1,2,4,5-四嗪(DATZ) |
107 |
WYQ |
2024-12-03 |
81588 |
3-d氨基-6-(3,5-二甲基乙基吡唑-1-基)-1,2,4,5-四嗪(ADMPT) |
122 |
WYQ |
2024-12-03 |
81589 |
[DOTA]LTT-SS28 ,生长抑素模拟物 |
139 |
wyh |
2024-12-03 |
81590 |
DOTA-minigastrin (CP04) , DOTA-小胃泌素(CP04) |
144 |
wyh |
2024-12-03 |
81591 |
DOTA-rhuEpo ; DOTA-酰肼偶联rhuEpo |
88 |
wyh |
2024-12-03 |
81592 |
1,2,4,5-四嗪 , 化学式:C2H2N4 |
159 |
WYQ |
2024-12-03 |
81593 |
DOTA-Benerotide ;靶向生长抑素受体 |
78 |
wyh |
2024-12-03 |
81594 |
1,2,4,5-Tetrazines by Palladium Catalysis(钯催化1,2,4,5-四嗪的合成) |
91 |
WYQ |
2024-12-03 |
81595 |
5-苯基-1,2,4-三嗪-3-胺为例,为C9H8N4 |
92 |
WYQ |
2024-12-03 |
81596 |
DOTA-PEG-LA-AuNP,DOTA-PEG-硫辛酸修饰纳米金纳米粒子 |
112 |
wyh |
2024-12-03 |
81597 |
3,6-二(吡啶-2-基)-1,2,4,5-四嗪(pytz) |
140 |
WYQ |
2024-12-03 |
81598 |
HYNIC-PEG11-Tz;联肼尼克酰胺-十一聚乙二醇-四嗪;HYNIC-PEG11-Tetrazine |
93 |
WYQ |
2024-12-03 |
81599 |
DOTA-NT肽偶联金纳米粒子 ,DOTA-NT-AuNPs |
87 |
wyh |
2024-12-03 |
81600 |
[Zr-89]Zr-DFO-PEG5-Tz;[Zr-89]Zr-DFO-PEG5-Tetrazine |
97 |
WYQ |
2024-12-03 |
81601 |
MeTz-NOTA-RGD;甲基四嗪-大环配体-多肽 |
131 |
WYQ |
2024-12-03 |
81602 |
DOTA-Tyr(3)-奥曲肽, DOTA-Tyr(3)-Octreotide |
74 |
wyh |
2024-12-03 |
81603 |
AgNPs–pytz(3,6-二(吡啶-2-基)-1,2,4,5-四嗪包覆的银纳米粒子) |
93 |
WYQ |
2024-12-03 |
81604 |
3,6-di(pyridin-2-yl)-1,2,4,5-s-tetrazine (pytz,3,6-二(吡啶-2-基)-1,4-二氢-1,2,4,5-四嗪) |
121 |
WYQ |
2024-12-03 |
81605 |
DOTA-叶酸偶联物,DOTA-Folate |
125 |
wyh |
2024-12-03 |
81606 |
CQDs-DOTA-Yb,镱-DOTA螯合物功能化碳量子点 |
104 |
wyh |
2024-12-03 |
81607 |
3,6-dihydrazino-s-tetrazine (DHT,3,6-二肼基-s-四嗪) |
117 |
WYQ |
2024-12-03 |
81608 |
BCN-PEG-PAMAM ,环丙烷环辛炔-聚乙二醇-聚酰胺 |
99 |
zyl |
2024-12-03 |
81609 |
(DNAZTzDMP)2Ni(H2O)2][NO3]2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 |
104 |
WYQ |
2024-12-03 |
81610 |
AB1-HLys-DOTA,DOTA偶联阳离子肽 |
92 |
wyh |
2024-12-03 |
81611 |
PAMAM-PEG-CKAAKN 树枝状大分子聚酰胺胺-聚乙二醇-CKAAKN多肽 |
100 |
zyl |
2024-12-03 |
81612 |
(NH2TzDMP)3Ni][NO3]2;3-氨基-6-(3,5-二甲基吡唑)四嗪配合物 |
80 |
WYQ |
2024-12-03 |
81613 |
(DNAZTzDMP)2Co(H2O)2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 |
118 |
WYQ |
2024-12-03 |
81614 |
DOTA-1-nal 3-奥曲肽,Ga-DOTA-1-Nal3-octreotide |
71 |
wyh |
2024-12-03 |
81615 |
PAMAM-PEG-SP94 树枝状大分子聚酰胺胺-聚乙二醇-SP94多肽 |
101 |
zyl |
2024-12-03 |
81616 |
[(DNAZTzDMP)2Co(H2O)2](3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物) |
128 |
WYQ |
2024-12-03 |
81617 |
LLP2A-DOTA-PEG(2000), LLP2A-DOTA-聚乙二醇(2000) |
88 |
wyh |
2024-12-03 |
81618 |
[(NH2TzDMP)2Co(H2O)(NO3)][NO3](3-氨基-6-(3,5-二甲基吡唑)四嗪配合物) |
84 |
WYQ |
2024-12-03 |
81619 |
3-(3,3'-dinitroazetidine)-6-(3,5-dimethylpyrazole)tetrazine(DNAZTzDMP) |
99 |
WYQ |
2024-12-03 |
81620 |
PAMAM-PEG-PTP 树枝状大分子聚酰胺胺-聚乙二醇-PTP多肽 |
93 |
zyl |
2024-12-03 |
81621 |
DOTA-SSTR;DOTA修饰生长抑素受体SSTR |
144 |
wyh |
2024-12-03 |
81622 |
NOTA-PEG(7)-Tz;大环化合物-七聚乙二醇-四嗪;NOTA-PEG(7)-Tetrazine |
109 |
WYQ |
2024-12-03 |
81623 |
PAMAM-PEG-RGDS 树枝状大分子聚酰胺胺-聚乙二醇-RGDS多肽 |
95 |
zyl |
2024-12-03 |
81624 |
PEGylated tetrazine;PEG4-Tz;聚乙二醇化四嗪;PEGylated Tz |
133 |
WYQ |
2024-12-03 |
81625 |
DOTA-ZOL, DOTA-唑来膦酸 |
86 |
wyh |
2024-12-03 |
81626 |
NHS-s-s-tetrazine;N-羟基琥珀酰亚胺-双硫键-四嗪;NHS-s-s-Tz |
111 |
WYQ |
2024-12-03 |
81627 |
PAMAM-PEG-c(RGDfC) ,树枝状大分子聚酰胺胺-聚乙二醇-c(RGDfC)多肽 |
142 |
zyl |
2024-12-03 |
81628 |
3-amino-6-(3,5-dimethylpyrazole)tetrazine(NH2TzDMP、3-氨基-6-(3,5-二甲基吡唑)四嗪) |
77 |
WYQ |
2024-12-03 |
81629 |
DOTA-cyclo(RGDyK) 生物医药探针 |
84 |
zcy |
2024-12-03 |
81630 |
Gd-DOTA-氮氧化合物,Gd-DOTA-NOx |
88 |
wyh |
2024-12-03 |